Myelopathy

Myelopathy
Classification and external resources
Specialty	neurology
ICD-10	G95
ICD-9-CM	336.9
DiseasesDB	22984
MeSH	D013118

Myelopathy describes any neurologic deficit related to the spinal cord.^[1] When due to trauma, it is known as (acute) spinal cord injury. When inflammatory, it is known as myelitis. Disease that is vascular in nature is known as vascular myelopathy. The most common form of myelopathy in human, cervical spondylotic myelopathy (CSM),^[2][3] is caused by arthritic changes (spondylosis) of the cervical spine, which result in narrowing of the spinal canal (spinal stenosis) ultimately causing compression of the spinal cord.^[4] In Asian populations, spinal cord compression often occurs due to a different, inflammatory process affecting the posterior longitudinal ligament.

Clinical signs and symptoms depend on which spinal cord level (cervical, thoracic or lumbar) is affected and the extent (anterior, posterior or lateral) of the pathology, and may include:

• upper motor neuron signs (weakness, spasticity, clumsiness, altered tonus, hyperreflexia and pathological reflexes, including Hoffmann's sign and inverted Plantar reflex (positive Babinski sign))
• lower motor neuron signs (weakness, clumsiness in the muscle group innervated at the level of spinal cord compromise, muscle atrophy, hyporeflexia, muscle hypotonicity or flaccidity, fasciculations)
• sensory deficits
• bowel/bladder symptoms and sexual dysfunction.

Diagnosis

Myelopathy is primarily diagnosed by clinical exam findings. Because the term myelopathy describes a clinical syndrome that can be caused by many pathologies the differential diagnosis of myelopathy is extensive.^[5] In some cases the onset of myelopathy is rapid, in others, such as CSM, the course may be insidious with symptoms developing slowly over a period of months. As a consequence, the diagnosis of CSM is often delayed.^[6] As the disease is thought to be progressive, this may impact negatively on outcome.

Once the clinical diagnosis myelopathy has been established, the underlying cause needs to be investigated. Most commonly this involves the use medical imaging techniques. The best way of visualising the spinal cord is Magnetic Resonance Imaging (MRI). Apart from T1 and T2 MRI images, which are commonly used for routine diagnosis, more recently the use quantitative MRI signals is being investigated.^[7] Further imaging modalities used for evaluating myelopathy include plain X-rays for detecting arthritic changes of the bones, and Computer Tomography, which is often used for pre-operative planning of surgical interventions for cervical spondylotic myelopathy. Angiography is used to examine blood vessels in suspected cases of vascular myelopathy.

The presence and severity of myelopathy can also be evaluated by means of Transcranial Magnetic Stimulation (TMS), a neurophysiological method that allows the measurement of the time required for a neural impulse to cross the pyramidal tracts, starting from the cerebral cortex and ending at the anterior horn cells of the cervical, thoracic or lumbar spinal cord. This measurement is called Central Conduction Time (CCT). TMS can aid physicians to:^[8]

• determine whether myelopathy exists
• identify the level of the spinal cord where myelopathy is located. This is especially useful in cases where more than two lesions may be responsible for the clinical symptoms and signs, such as in patients with two or more cervical disc hernias^[9]
• follow-up the progression of myelopathy in time, for example before and after cervical spine surgery

TMS can also help in the differential diagnosis of different causes of pyramidal tract damage.^[10]

Prognosis and Treatment

The treatment and prognosis of myelopathy depends on the underlying cause: myelopathy caused by infection requires medical treatment with pathogen specific antibiotics. Similarly, specific treatments exist for multiple sclerosis, which may also present with myelopathy. As outlined above, the most common form of myelopathy is secondary to degeneration of the cervical spine. Newer findings have challenged the existing controversy with respect to surgery^[11] for cervical spondylotic myelopathy by demonstrating that patients benefit from surgery.^[12]

See also

• Surfer's myelopathy

References

1. "Myelopathy" at American Journal of Neuroradiology
2. "The Science of CSM". Myelopathy.org: an online resource for cervical spondylotic myelopathy. Retrieved 2015-11-05.
3. Wu, Jau-Ching; Ko, Chin-Chu; Yen, Yu-Shu; Huang, Wen-Cheng; Chen, Yu-Chun; Liu, Laura; Tu, Tsung-Hsi; Lo, Su-Shun; Cheng, Henrich (2013-07-01). "Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury: a national cohort study". Neurosurgical Focus 35 (1): E10. doi:10.3171/2013.4.FOCUS13122.
4. Shedid, Daniel; Benzel, Edward C. "CERVICAL SPONDYLOSIS ANATOMY". Neurosurgery 60 (SUPPLEMENT): S1–7???S1–13. doi:10.1227/01.neu.0000215430.86569.c4.
5. Kim, Han Jo; Tetreault, Lindsay A.; Massicotte, Eric M.; Arnold, Paul M.; Skelly, Andrea C.; Brodt, Erika D.; Riew, K. Daniel. "Differential Diagnosis for Cervical Spondylotic Myelopathy". Spine 38: S78–S88. doi:10.1097/brs.0b013e3182a7eb06.
6. "http://thejns.org/doi/abs/10.3171/2013.3.FOCUS1374)". doi:10.3171/2013.3.focus1374). External link in |title= (help)
7. Ellingson, Benjamin M.; Salamon, Noriko; Grinstead, John W.; Holly, Langston T. "Diffusion tensor imaging predicts functional impairment in mild-to-moderate cervical spondylotic myelopathy". The Spine Journal 14 (11): 2589–2597. doi:10.1016/j.spinee.2014.02.027. PMC 4426500. PMID 24561036.
8. Chen R, Cros D, Curra A, Di Lazzaro V, Lefaucheur JP, Magistris MR, Mills K, Rösler KM, Triggs WJ, Ugawa Y, Ziemann U. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol. 2008 Mar;119(3):504-32.
9. Deftereos SN, et al. (April–June 2009). "Localisation of cervical spinal cord compression by TMS and MRI". Funct Neurol 24 (2): 99–105. PMID 19775538.
10. Chen R, Cros D, Curra A, et al. (March 2008). "The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee". Clin Neurophysiol 119 (3): 504–32. doi:10.1016/j.clinph.2007.10.014. PMID 18063409.
11. Nikolaidis, Ioannis; Fouyas, Ioannis P; Sandercock, Peter AG; Statham, Patrick F (2010-01-20). Surgery for cervical radiculopathy or myelopathy. John Wiley & Sons, Ltd. doi:10.1002/14651858.cd001466.pub3. ISSN 1465-1858.
12. Fehlings, Michael G.; Wilson, Jefferson R.; Kopjar, Branko; Yoon, Sangwook Tim; Arnold, Paul M.; Massicotte, Eric M.; Vaccaro, Alexander R.; Brodke, Darrel S.; Shaffrey, Christopher I. (2013-09-18). "Efficacy and Safety of Surgical Decompression in Patients with Cervical Spondylotic Myelopathy". The Journal of Bone & Joint Surgery 95 (18): 1651–1658. doi:10.2106/JBJS.L.00589. ISSN 0021-9355. PMID 24048552.